LYON, France--(BUSINESS WIRE)--Regulatory News: These encouraging findings from the IASO Phase 1b trial confirm the favorable safety and tolerability profile of MaaT033 in ALS patients. They also ...
Passage of the ALS Association-led bill marks a milestone in the fight to alleviate crushing costs incurred by ALS patients and their families AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- The ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback